Onconova Therapeutics, Inc.
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressive K-Ras mutated non-small cell lung cancer; and in Phase 1b/2 for recessive dystrophic epidermolysis bullosa. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. The company has a license agreement with SymBio Pharmaceuticals Limited; and license, development, and commercialization agreement with Pint International SA. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania. Show More...
-
Website http://www.onconova.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 7.93 USD
-
Last Updated 03-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -294.39 -328.88 -918.0 -441.0 -158.1 -66.6 -40.15 -4.99 -1.49 -0.23 Dividends USD Payout Ratio % * Shares Mil 1.0 4.0 14.0 53.0 Book Value Per Share * USD 655.62 243.75 19.84 20.38 -9.62 1.91 -0.05 0.13 Free Cash Flow Per Share * USD -509.0 -422.11 -276.9 -73.7 -43.49 -7.64 -3.54 Return on Assets % -679.38 -76.69 -68.64 -83.52 -67.75 -84.27 -170.79 -179.66 -103.39 -87.51 Financial Leverage (Average) 1.95 1.31 2.08 2.34 5.41 3.33 2.05 1.5 Return on Equity % -105.11 -123.46 -146.4 -274.93 -253.56 -191.75 Return on Invested Capital % -105.1 -123.46 -146.4 -274.93 -253.56 -191.75 Interest Coverage -2.47 Current Ratio 0.32 3.28 10.1 4.57 3.05 2.27 0.49 2.11 2.83 4.61 Quick Ratio 0.26 3.21 9.67 4.25 2.8 2.11 0.41 2.02 2.75 4.5 Debt/Equity